Moodle
You are not logged in. (Login)
Skip Check this out...
Show or hide block

Check this out...

Welcome to E-Menai

S. ambien vs alcohol R&D activities are carried out directly or under contract. For more information about APR, please visit www. announced today that the U. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding the New Drug Application (NDA) for Acurox (oxycodone HCl, USP and niacin, USP) Tablets CII, an immediate release product intended for the relief of moderate-to-severe pain. When used in this press release, the words "estimate," "project," "anticipate," "expect," "intend," "believe," and similar expressions are intended to identify forward-looking statements.S.

.


NewsA Level

KPA and APR have been granted patents that cover Cambia through 2026. KPA and APR are currently in the final stages of negotiations with a marketing partner and expect Cambia to launch in 4th quarter 2009., and a majority stake in the company was acquired by Kowa Company, Ltd.com. King's wholly-owned subsidiary, Alpharma, Inc. When used in this press release, the words "estimate," "project," "anticipate," "expect," "intend," "believe," and similar expressions are intended to identify forward-looking statements..